Document is current
Any future updates will be listed below
-
Authors
Li, Chenyu
Richards, Shola M.
Quinn, Ghazal
Abedini, Amin https://orcid.org/0000-0002-8875-0070
Zhu, Minyan
Verma, Tanya
Mohandes, Samer
Pitts, Rebecca https://orcid.org/0000-0003-4733-414X
Barros, Vesna
Qiu, Xiazi
Shin, Taehwan
Loureiro, Joseph J. https://orcid.org/0000-0001-7222-9160
Finkel, Nancy
Surapaneni, Aditya
Coresh, Josef https://orcid.org/0000-0002-4598-0669
Grams, Morgan E. https://orcid.org/0000-0002-4430-6023
Karihaloo, Anil
Li, Hongzhe https://orcid.org/0000-0003-3662-3907
Verma, Anurag https://orcid.org/0000-0002-5063-9107
Ritchie, Marylyn https://orcid.org/0000-0002-1208-1720
Rader, Daniel J. https://orcid.org/0000-0002-9245-9876
,
Dietrich, William F.
Jennings, Lori L.
Susztak, Katalin https://orcid.org/0000-0002-1005-3726
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK076077, R01 DK087635, and R01 DK105821)
- License Information
-
More Information
Article History
Received: 16 September 2025
Accepted: 10 March 2026
First Online: 15 April 2026
Competing interests
: The laboratory of K.S., including C.L., G.Q., A.A., M.Z., T.V. and S.M., receives research support from Gilead, Novo Nordisk, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Regeneron, Genentech and Calico Life Sciences. J.C. is a scientific advisor receiving fees from SomaLogic and Healthy.io. S.M.R., R.P., V.B., X.Q., T.S., J.J.L., N.F., W.F.D. and L.L.J. are employees and stockholders of Novartis. A.K. is an employee of Novo Nordisk. The remaining authors declare no competing interests.
